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Abstract 15	
Biliary excretion is one of the main elimination pathways for drugs and/or their metabolites. 16	
Therefore, an insight into the structural profile of cholephilic compounds through accurate 17	
modelling of the biliary excretion is important for the estimation of clinical pharmacokinetics 18	
in early stages of drug discovery. The aim of this study was to develop Quantitative 19	
Structure-Activity Relationships (QSAR) as computational tools for the estimation of biliary 20	
excretion and identification of the molecular properties controlling this process. The study 21	
used percentage of dose excreted intact into bile measured in vivo in rat for a diverse dataset 22	
of 217 compounds. Statistical techniques were multiple linear regression analysis, regression 23	
trees, random forest and boosted trees. A simple regression tree model generated using the 24	
CART algorithm was the most accurate in the estimation of the percentage of bile excretion 25	
of compounds and this outperformed the more sophisticated boosted trees and random forest 26	
techniques. Analysis of the outliers indicated that the models perform best when lipophilicity 27	
is not too extreme (log P < 5.35) and for compounds with molecular weight above 280 Da. 28	
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Molecular descriptors selected by all these models including the top ten incorporated in 29	
boosted trees and random forest indicated a higher biliary excretion for relatively hydrophilic 30	
compounds especially if they are anionic or cationic, and have a large molecular size. A 31	
statistically validated molecular weight threshold for potentially significant biliary excretion 32	
was above 348 Da. 33	
 34	
Keywords: Biliary excretion, QSAR, CART, bile, pharmacokinetic  35	
	3	
	
INTRODUCTION 36	
Biliary excretion is an important route for the elimination of some drugs and their metabolites 37	
(1). Although the liver is generally identified with its role in metabolism, one of the most 38	
important functions of the liver is formation of bile which is then stored in the gallbladder 39	
and discharged into the duodenum upon ingestion of food, with bile carrying also cholephilic 40	
xenobiotics. Bile which is a composition of bile acids and other components such as 41	
phospholipids, bilirubin and cholesterol is formed in the hepatocytes and is actively 42	
discharged across the canalicular membrane into canaliculus (2). Once bile is released into 43	
the intestine, some metabolites and unchanged drugs continue their way of elimination 44	
through the faeces. Others, for example lipid-soluble drugs, are reabsorbed from the intestine 45	
and move to the systemic circulation (2). This enterohepatic circulation affects 46	
pharmacokinetics by keeping the plasma concentration of drugs high (1). Enterohepatic 47	
cycling and biliary elimination can continue until the compound is ultimately eliminated from 48	
the body by faecal or renal excretion or metabolism. 49	
Uptake from sinusoidal blood and then secretion of bile salts across the canalicular 50	
hepatocyte membrane are the major factors controlling the rate of bile secretion. Figure 1 51	
illustrates a schematic representation of some of the important transporters that are involved 52	
in this process. Basolateral bile salt uptake is driven through the Na+-dependent and Na+-53	
independent uptake systems (3). The main sodium dependent bile salt transporters are Na+-54	
taurocholate cotransporting polypeptides, NTCP (human) and Ntcp (rat). On the other hand, 55	
the Na+-independent uptake of bile salts cannot be attributed to the function of a single 56	
transport system and several carrier systems have been implicated including sulphate/anion 57	
exchanger, dicarboxylate/anion exchanger and OH-/cholate exchanger. In rats, the organic 58	
anion transporting polypeptides Oatp1, Oatp2 and Oatp4 have been indicated as the main 59	
sodium independent uptake proteins (3). The organic cation and organic anion transporters 60	
(OCT and OAT respectively) also play important roles in the initial sinusoidal influx of drugs 61	
into hepatocytes (4). These transporters have wide substrate specificities for a range of 62	
exogenous and endogenous substrates (5). OCT1 can be found abundantly in hepatocytes and 63	
may be seen as the most important transporter for distribution of cationic compounds into the 64	
liver from sinusoidal membrane (6). 65	
Canalicular bile secretion is an osmotic process in which active excretion of organic solutes 66	
into the bile canaliculus is the main driving force for the passive inflow of water, electrolytes, 67	
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and nonelectrolytes from hepatocytes (7). While products of the multidrug resistance gene 68	
family (Mdr), namely bile salt export pumps, Bsep (rat) and BSEP (human), transport 69	
monovalent bile salts (2), excretion of non-bile salt organic anions and divalent sulphate or 70	
glucuronide bile salts is carried mainly by the multidrug resistance protein 2 (MRP2). Bile 71	
salt export pump has a limited role in drug excretion. However, drug inhibition of this pump 72	
can lead to hepatotoxicity (8). Another member of this family, P-Glycoprotein (P-gp), also 73	
known as Multidrug Resistance Protein1 (MDR1), actively effluxes xenobiotics into the bile 74	
(9). Breast cancer resistance protein (BCRP/ABCG2) is also involved in the transport of a 75	
range of drugs. For example nitrofurantoin has a very high biliary excretion predominantly 76	
mediated by BCRP (10). Other basolateral isoforms of the multidrug resistance-associated 77	
protein, MRP1 and MRP3, provide alternative routes for the elimination of organic anions 78	
from hepatocytes into the systemic circulation (3). 79	
Properties of the chemical structure as well as the characteristics of the liver such as specific 80	
active transport sites within the liver cell membranes are the main factors which determine 81	
the elimination of xenobiotics via the biliary tract (2). Despite the various transport systems 82	
involved in the biliary elimination of xenobiotics, there has been a number of attempts to 83	
identify common molecular features of highly excreted compounds. Molecular weight (MW) 84	
has been suggested as an important factor in biliary excretion levels of compounds. Anionic 85	
compounds with the MW higher than 325±50 kDa in rats, 400±50 kDa in guinea pigs, 47586	
±50 kDa in rabbits and 500±50 kDa in human have been suggested as good candidates for 87	
biliary excretion (11). Most compounds with lower molecular weights are quickly cleared 88	
through the kidneys and are not excreted in the bile (12). Bile is rich in endogenous organic 89	
anionic substrates (e.g., steroid hormones), organic cations (such as quaternary ammonium), 90	
bilirubin, and bile acids (2). Moreover, excretion route of anionic xenobiotics and some 91	
antibacterials is through the bile (13). Principally, for organic cationic compounds, biliary 92	
elimination depends on the molecular volume (14), lipophilicity of the compound and the 93	
number of cationic groups (15). 94	
Biliary excretion has major significance in determining the pharmacokinetic profiles of drugs. 95	
In several disease states, the excretion of drugs through bile is affected and toxicities may 96	
arise (1, 2). Knowledge of biliary excretion levels of compounds can help in identifying any 97	
possible mechanisms of hepatobiliary toxicity and potential drug–drug interactions. Therefore, 98	
an insight into the structural profile of cholephilic compounds through accurate modelling of 99	
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the biliary excretion is important for predicting clinical pharmacokinetics. This is of a 100	
particular value during earlier stages of drug discovery where low-cost estimation procedures 101	
are required. Quantitative Structure-Activity Relationships (QSARs) employ data mining 102	
techniques to explore the relationships between biological properties of interest, e.g. 103	
pharmacokinetic parameters of drugs, and the properties of the molecular structures (16). 104	
Recently, a QSAR model developed using 2D molecular descriptors showed good prediction 105	
ability for a set of literature biliary excretion data measured under the same experimental 106	
model (17). However, re-evaluation of this simple model showed that the statistical 107	
significance of the model is lost when it is used for the prediction of a wide set of external 108	
compounds (18), suggesting that hepatobiliary excretion cannot be captured by simple 109	
physicochemical descriptors when examining chemically dissimilar compounds.  110	
Unfortunately, availability of in vivo biliary excretion data which is necessary for modelling 111	
is very limited. Yang et al (19) have recently compiled a big dataset of percentage of dose 112	
eliminated in the bile in rats and humans. This offers an excellent resource for a detailed 113	
study on the structural determinants for high biliary excretion. Using this data set, Yang and 114	
co-workers suggested a MW threshold of 400 Da for anions in rats and 475 Da for anions in 115	
humans. They also developed linear regression models for human and rat. The aim of this 116	
study was to use an expanded dataset and incorporate non-linear methods to develop 117	
statistically valid QSAR models. Specifically, classification and regression tree (CART) is a 118	
flexible and yet simple and interpretable technique with embedded feature selection that 119	
selects the most significant molecular descriptor for partitioning the data into smaller subsets 120	
of similar observations (20). This rule based technique is a decision tree that splits the data in 121	
a recursive manner until the subset has all the same value of the target (dependent) variable, 122	
or when no gain in the prediction accuracy is achievable by further splitting. In this study we 123	
aimed at using regression trees and two ensemble methods that construct many such decision 124	
trees and return the consensus prediction by the trees, namely random forest and boosted 125	
trees. The prediction accuracy of the models and the molecular descriptors selected by these 126	
methods were compared in order to clarify the structural elements controlling the biliary 127	
excretion. Moreover, regression trees were used to examine the significance of molecular 128	
weight and presence of carboxylic acid group and to find the statistically significant threshold 129	
values. In this case, regression trees are useful since they can be used interactively so that a 130	
molecular descriptor of choice can be incorporated at any split level and the analysis may 131	
determine the statistically significant threshold value of the descriptor for splitting the data.  132	
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METHODS 134	
Dataset 135	
The biliary excretion dataset collated by Yang et al (19), available at 136	
http://www.acsu.buffalo.edu/~memorris/Suppl%20Data_Rats_052909_pdb.pdf, plus some 137	
additional data from the original literature were used in this study (See Supplementary 138	
Material I for the dataset and the reference list). It consists of in vivo biliary excretion 139	
expressed as percentage of dose excreted as the parent compound intact through the bile 140	
(BE%) for 217 compounds in rat after iv or intraperitoneal administration of the compound. 141	
The compounds are from different chemical classes such as bile acids, statins, dyes, 142	
penicillins and cephalosporines, macrolide antiobiotics, quinolone antibiotics, NSAIDs, 143	
thrombin inhibitors, analgesics, anti-cancer drugs such as doxorubicin, folates, peptides, anti-144	
HIV agents, quaternary ammoniums, sulphanilamide and arylaminosulphonic acids. 145	
 146	
Molecular Descriptors  147	
Molecular descriptors were calculated for the 217 compounds using ACD Labs/logD suite 148	
version 12, TSAR 3D version 3.3 (Accelryl Inc), Molecular Operation Environment (MOE) 149	
version 2011.10 (Chemical Computing Group) and Symyx QSAR software (Accelryl Inc). 150	
The fractions of ionised compounds at pH 7.4 as acid (fiA), as base (fiB), or, for zwitterionic 151	
compounds ionized as acid and base (fiAB) and fraction unionised (fU) were calculated using 152	
equations 1 to 4 and used as additional molecular descriptors: 153	
fiA	= ##$%&'()*+(-.%/0.2	)                                                 (Eq. 1) 154	
fiB = ##$%&'()*+(0.2/-.%	)                                                 (Eq. 2) 155	
fiAB = fiA . fiB                                                                                 (Eq. 3) 156	 fU = (1-fiA) . (1-fiB)                                                                         (Eq. 4) 157	
 158	
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In equations 1 and 2 pKa was the most acidic pKa and the most basic pKa respectively, 159	
which were obtained from ACD Labs pKa database and, in case experimental pKa was not 160	
available, it was calculated by the software.  161	
In MOE, following the wash procedure which removed salt forms, energy minimization was 162	
carried in order to calculate atomic coordinates corresponding to the local minimum (the low 163	
energy conformation). Thereafter, self-consistent field (SCF) calculations were performed, 164	
and this latter energy minimized structure was used for the calculation of all the molecular 165	
descriptors. Before building the models, the molecular descriptors were checked to find and 166	
discard those columns containing more than 98% constant values or more than 28 (out of 217) 167	
missing values. The total number of descriptors used in all statistical analyses was 387. 168	
 169	
Model development and validation 170	
Several linear and non-linear methods were used for the QSAR model development. The 171	
compounds were divided into an external validation set and a training data. Models were 172	
developed using training set compounds and assessed using internal and external validation 173	
sets. To divide the compounds, they were ordered according to BE% and from every set of 174	
five compounds, four were allocated into the training and one into the external validation set 175	
randomly. In this way, training data consisted of 168 compounds and the external validation 176	
set consisted of 40 compounds. For the analytical methods that required parameter 177	
optimization, a fraction of training set compounds were randomly assigned into internal 178	
validation set, or alternatively cross validation was used if the option was available in the 179	
statistical software. STATISTICA Data Miner was the software used for statistical analysis. 180	
For the internal validation set, where applicable, the risk estimate and standard error were 181	
calculated in STATISTICA software and used as the performance indicators. Risk estimate is 182	
calculated as the proportion of residual variance incorrectly estimated by the model. Standard 183	
error measures the error of the prediction.  184	
Mean absolute error (MAE) was used to assess the accuracy of prediction of biliary excretion 185	
using the selected models (eq. 5). 186	
 187	
MAE = |(*789:;9<		 /-:9<(='9<)|>                                                     (Eq. 5) 188	
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In equations 5, ‘observed’ refers to the log percentage of intact dose excreted into the bile 189	
from in vivo studies (LogBE%), ‘predicted’ is the predicted LogBE% by the QSAR models 190	
and N is the number of compounds. In all statistical analyses, the logarithm of percentage 191	
dose excreted (LogBE%) was used in the analysis instead of BE%. This was due to the 192	
normal distribution of LogBE% as indicated by the skewness comparison with BE%. 193	
 194	
Stepwise Regression analysis 195	
Minitab Statistical Software Version 16 was used for the development of multiple linear 196	
regression (MLR) models. In stepwise regression analysis, LogBE% was the dependant 197	
variable and all the molecular descriptors were the independent variables. In all regression 198	
analyses, a P value of less than 0.05 was considered to be statistically significant for variables. 199	
Values for “alpha to enter” and “alpha to remove” were set to 0.05. 200	
 201	
Classification and regression trees (C&RT) 202	
C&RT routine in STATISTICA version 11 (StatSoft Inc) was used to develop Regression 203	
Trees (RTs). The analysis builds an optimal tree structure to predict continuous dependent 204	
variables via V-fold cross-validation. In C&RT analysis LogBE% was the dependent variable 205	
and the predictors were selected by this statistical analysis from all the molecular descriptors 206	
provided. The size of a tree in C&RT analysis is an important issue, since an unreasonably 207	
big tree can lead to overfitting and can make the interpretation of the results more difficult. 208	
Several stopping criteria were examined, including the default settings in STATISTICA. The 209	
default stopping criteria were minimum number of cases of 21 and the maximum number of 210	
nodes set to 100. The default v-value of 10 was used in the v-fold cross-validation and the 211	
risk-estimate was used to check the reliability of the resulting RTs. 212	
 213	
Boosted Trees 214	
Boosted trees analysis in STATISTICA generates a series of very simple boosting regression 215	
trees (BT) where each successive tree is built for the prediction of residuals of the preceding 216	
tree. Each of these trees has weak predictive accuracy but using the weak predictors together 217	
can create a strong predictor (21). The default values for learning rate, the number of additive 218	
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terms (number of trees), random test data proportion (percentage of data points in testing pool) 219	
and subsample proportion were 0.1, 200, 0.2 and 0.5 respectively. Various subsample 220	
proportions of 0.4, 0.45, 0.50, 0.55 and 0.60 were examined in combination with the learning 221	
rates of 0.1 and 0.05. The best two models were selected based on the performance indicators 222	
for the internal validation set. The seed for random number generation which controls which 223	
cases are selected in sampling was set to one. The maximum number of nodes was set to 224	
three which means that each tree will have just one binary split.  225	
 226	
Random Forest 227	
A random forest (RF) model is an ensemble of tree predictors such that each tree depends on 228	
the values of a random vector (a random selection of molecular descriptors and training set 229	
compounds) sampled independently. The method builds a series of simple trees where the 230	
predictions are taken to be the average of the predictions of all the trees (22). Various 231	
subsample proportions of 0.40, 0.45, 0.50, 0.55 and 0.60 were examined while the number of 232	
predictors (to be randomly considered at each node) was 9.  Different numbers of trees were 233	
tested at 20, 50, 80, 100 and 200. The random test data proportion was 0.2 for the internal 234	
validation. The default settings were used for stopping conditions including minimum 235	
number of cases, maximum number of levels, minimum number in child node and the 236	
maximum number of nodes of 6, 10, 5 and 100, respectively. The best model was selected 237	
based on the estimation error for the internal test data. 238	
 239	
RESULTS 240	
A total of 387 2D (e.g. kappa shape indexes, molecular connectivity indexes and 241	
electrotopological state indexes) and 3D molecular descriptors were used for the QSAR 242	
model development. Out of 217 compounds in the rat biliary excretion dataset, 9 compounds 243	
had excretion rate of 0% and hence LogBE% could not be calculated for them, 168 244	
compounds in the training set were employed for the model development and the remaining 245	
40 compounds served as the external validation set. The method of data allocation into 246	
training and test sets outlined above ensured that a similar biliary excretion and molecular 247	
property spaces were covered by both the training and the validation sets. BE% values ranged 248	
between 0.048-100 with mean LogBE% values for the training and validation sets at 1.04 and 249	
1.01, respectively. LogP was between -3.44 and 18.8 for the training set, and -3.17 and 7.83 250	
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for the validation set with similar mean values of 1.81 and 1.83 respectively. Molecular 251	
weights of the compounds were between 122-1215 Da for the training set and 94-1255 Da for 252	
the validation set, with mean values of 457 and 390 respectively. Scores plot from principle 253	
component analysis using all the molecular descriptors also indicates similar chemistry space 254	
for the two sets (Figure S1 in Supplementary Material II).  255	
 256	
Regression models 257	
Stepwise regression analysis using in vivo rat biliary excretion data as the dependant variable 258	
resulted in the MLR model below in which the number of molecular descriptors is limited to 259	
eight. The statistical terms of the equation are N the number of compounds, R2 the correlation 260	
coefficient, S the standard deviation and F the Fisher’s statistics and the P value. Observed vs 261	
calculated logBE% by this equation has been plotted (Figure S2 in Supplementary Material 262	
II), with training and validation sets identified in the plot.  263	
 264	
LogBE% = 2.09 + 0.00129 vsurf_HB4 - 9.33 PEOE_RPC+ - 0.0574 SsCH3 - 0.377 fU - 265	
0.00503 SlogP_VSA0 - 0.0573 SsssCH + 0.0403 AM1_dipole + 0.378 SddssS_acnt      266	
 Eq. 6 (MLR Model) 267	
N = 168    S = 0.489    R-Sq = 0.608     F = 30.9    P = 0.000 268	
 269	
Molecular descriptors of this equation are not intercorrelated (R2 < 0.4). Table I gives a brief 270	
description of molecular descriptors used in this model. Vsurf_HB4 is the first molecular 271	
descriptor selected by the analysis and it indicates that compounds with high H-bond donor 272	
capacity have higher biliary excretion level. AM1_dipole (dipole moment) is the other 273	
polarity descriptor which has a positive effect. On the other hand, the equation shows that 274	
drugs with greater relative positive partial charge (PEOE_RPC+) have lower biliary excretion. 275	
The value of this descriptor is large for small acidic molecules such as benzoic acid and 276	
salicylic acid and therefore the small size of such compounds may be the reason for the 277	
reduced biliary excretion. In this equation, fU with a negative coefficient indicates that 278	
compounds with higher unionized fraction at pH 7.4 have lower biliary excretion. In other 279	
words, although according to fU, acidity and basicity (dissociation in general) increase the 280	
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biliary excretion of compounds, this is true only for large dissociated molecules. The positive 281	
effect of polarity and dissociation on biliary excretion is in agreement with the literature 282	
where for example polar surface area (18) and an acidity indicator (17, 23) have been 283	
included in linear QSAR models. Also according to this equation, compounds containing 284	
many methyl groups (SsCH3) and those that are highly branched containing >CH- groups 285	
(SsssCH) have lower biliary excretion. In this equation, SlogP_VSA0 shows the negative 286	
impact of the presence of atoms with logP(o/w) contribution of less than or equal to -0.4. 287	
SddssS_acnt indicates the direct effect of sulphate or sulphonamide groups. Sulphate and 288	
sulphonamide groups are found in sulphonamide drugs such as succinylsulphathiazole, dyes 289	
such as methyl orange and sulphate conjugates such as estrone 3-sulphate which may be 290	
substrates of MRP2 or BCRP (24). 291	
Table I. A brief description of the most important molecular descriptors selected and used by 292	
the models. Descriptors of RF and BTs are the top 10 most important descriptors. 293	
Descriptor Model Description 
a_acc RF Number of H-bond acceptor atoms. 
a_hyd BT (1) Number of hydrophobic atoms. 
AM1_dipole MLR,  
RT (1) 
Dipole moment calculated using AM1 Hamiltonian. 
BCUT_PEOE_0 RF The BCUT descriptor calculated from the eigenvalues of a 
modified adjacency matrix. The resulting eigenvalues are 
sorted and the smallest, 1/3-ile, 2/3-ile and largest 
eigenvalues are reported, in this case the 2/3-ile. The 
diagonal takes the value of the PEOE partial charges. 
CASA- RT (3) Negative charge weighted surface area, ASA- times max { qi 
< 0 }. 
chi1 RF First order molecular connectivity index  
COOH RT (3) Indicator variable for the presence of carboxylic acid group 
in the molecular structure 
Docking energy 
(MOE) 
RF Docking score (kcal/mol) for enzyme-ligand docking of the 
compounds into the active site of mouse P-glycoprotein from 
PDB calculated using MOE software 
FASA_H RT (1) Fractional ASA_H calculated (water accessible surface area 
of all hydrophobic atoms) as ASA_H / ASA. 
FCASA- RT (2) Fractional CASA- calculated as CASA- / ASA. 
fU MLR,  
RT (1) 
Fractions of compounds unionised. 
GCUT_SLOGP_1 RT (1) The GCUT descriptors are calculated from the eigenvalues 
of a modified graph distance adjacency matrix. Each ij entry 
of the adjacency matrix takes the value 1/sqr(dij) where dij is 
the (modified) graph distance between atoms i and j. The 
resulting eigenvalues are sorted and the smallest, 1/3-ile, 
2/3-ile and largest eigenvalues are reported. The diagonal 
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Descriptor Model Description 
takes the value of the atomic contribution to logP. 
Kier2 BT (1), 
BT (2) 
Second order kappa shape index: (n-1)2 / m2 
Kier3 BT (1), 
BT (2) 
Third order kappa shape index: (n-1)2 / m2  
KierA1 RT (2) First order alpha modified shape index: s (s-1)2 / m2 where 
s = n + a  
KierA3 BT (1), BT (2) 
Third order alpha modified shape index: (n-1) (n-3)2 / p32 for 
odd n, and (n-3) (n-2)2 / p32 for even n where s = n + a  
LogD (5.5) BT (2) Logarithm of distribution coefficient D of a compound 
between octanol and buffer layers at pH value 5.5 
LogD (6.5) RT (1), 
RT (2), 
BT (1), 
BT (2) 
Logarithm of distribution coefficient D of a compound 
between octanol and buffer layers at pH value 6.5 
LogD (7.4) BT (1), BT (2) 
Logarithm of distribution coefficient D of a compound 
between octanol and buffer layers at pH value 7.4 
LogD (10) RT (3), BT (2) 
Logarithm of distribution coefficient D of a compound 
between octanol and buffer layers at pH value 10 
MW RT (2) 
RF 
The molecular weight 
N ratio RT (1) The weight ratio of nitrogen atoms in the molecule 
PEOE_PC- RT (3) Total negative partial charge 
PEOE_RPC+ MLR,  
BT (2) 
Relative positive partial charge: the largest positive atomic 
charge divided by the sum of the positive partial charges 
PEOE_VSA_NEG RT (2) Total negative van der Waals surface area. 
PEOE_VSA-0 RT (1) Van der Waals surface area of atoms with atomic charge in 
the range (-0.05, 0.00) 
PEOE_VSA_FPP
OS 
RF Fractional positive polar van der Waals surface area. This is 
the sum of the VDW surface area such that partial charge of 
atom is greater than 0.2. 
PEOE_VSA_HYD BT (1), 
BT (2) 
Total hydrophobic van der waals surface area. This is the 
sum of the van der waals surface area such that absolute 
value of atomic charge is less than or equal to 0.2. 
Q_PC+ RF Total positive partial charge: the sum of the positive partial 
charge of atoms in the molecule 
SddssS_acnt MLR Count of all sulphur atoms (ddssS) E-state indexes in 
molecule 
SlogP_VSA0 MLR Sum of approximate accessible van der Waals surface area 
for atoms with atomic contribution to logP(o/w) of equal or 
less than -0.4 
SMR_VSA7 RT (2) Sum of approximate accessible van der Waals surface area 
for atoms with atomic contribution to molar refractivity of Ri 
> 0.56 
SsCH3 MLR Atom type electrotopological state index (sum of the E-
states) for (-CH3) groups 
SsssCH MLR Sum of E-State for all (>CH- ) groups in molecule. 
SssssC RT (2) Sum of all (> C <) E-State value in molecule. 
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Descriptor Model Description 
TPSA RF Topological polar surface area (Å2) 
VAdjEq RF Vertex adjacency information (equality): This is an atom 
count /bond count descriptor calculated as:  
 -(1-f)log2(1-f) - f log2 f  
where f = (n2 - m) / n2, n is the number of heavy atoms and 
m is the number of heavy-heavy bonds. If f is not in the open 
interval (0,1), then 0 is returned. 
vsa_hyd BT (1) Approximation to the sum of VDW surface areas of 
hydrophobic atoms (Å2) 
vsurf_CW4 RT (2) Capacity factor is the ratio of the hydrophilic surface over 
the total molecular surface, calculated at eight different 
energy levels (from -0.2 to -6.0 kcal/mol) 
vsurf_EDmin3 RT (1) The lowest hydrophobic energy 
vsurf_HB4  
vsurf_HB5 
vsurf_HB6 
MLR, 
BT (1), 
BT (1) 
H-bond donor capacity at -2.0 Kcal/mol with carbonyl 
oxygen probe 
vsurf_ID7 RT (1) Hydrophobic integy moment (The "integy moment" is 
defined in analogy to the dipole moment and describes the 
distance of the centre of mass to the barycenter of 
hydrophobic regions). Small integy moment indicates that 
the hydrophobic moieties are either close to the centre of 
mass or they balance at opposite ends of the molecule, so 
that their resulting barycentre is close to the centre of the 
molecule. VolSurf computes ID at eight different energy 
levels (from -0.2 to 1.6 Kcal/mol). 
vsurf_IW2 RT (2), 
BT (2) 
Hydrophilic integy moment (see vsurf_ID7) 
vsurf_W1 
vsurf_W3 
RF, 
RT (1) 
Hydrophilic volume 
 294	
Regression tree models using CART 295	
Several Regression Trees (RTs) were generated using a combination of molecular descriptors 296	
while cross-validation was applied (Table II). As seen in Table II, in RT (1), molecular 297	
descriptors were selected by C&RT analysis, while in RT (2) the molecular weight and in RT 298	
(3) the number of carboxylic acid groups were manually imposed as the first split descriptor 299	
using Interactive C&RT routine in STATISTICA. These models were developed using the 300	
training set and the validation set remained external. The RTs resulting from these trials have 301	
been presented in Figures 2 – 4. In the regression trees, N is the number of compounds, Mu is 302	
the average and Var is the variance of LogBE% in each node. The molecular descriptors 303	
employed in the trees have been explained in Table I. Table III provides the statistical 304	
parameters of the regression trees. Observed vs calculated logBE% plots are in 305	
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Supplementary Material II (Figures S3-S5) with training and validation sets identified in the 306	
plots.  307	
Table II. Description of the Regression Trees 308	
Model 
No 
Manually incorporated 
variables 
RT (1) None 
RT (2) Molecular weight 
RT (3) Carboxylic acid group 
 309	
According to RT (1), biliary excretion is much higher for compounds with large hydrophilic 310	
volume (vsurf_W3), especially if they are ionized with fU £ 0.001 (negligible unionized 311	
fractions at pH 7.4). Within the hydrophilic drugs of higher fU values (node 7), those with 312	
higher separation of lipophilic interaction sites from the centre of mass (vsurf__ID7 > 0.760) 313	
have higher biliary excretion. Surfactant molecules and glucuronide conjugates are examples 314	
of such molecules with high VolSurf integy moment (vsurf_ID7) and high biliary excretion. 315	
This branch follows to partition the molecules further according to GCUT_SLOGP_1 with 316	
compounds of lower hydrophobicity (node 18), and large hydrophobic interaction energy 317	
minima (vsurf_EDmin3 > -2.60) showing high biliary excretion (node 23). According to RT 318	
(1), the less hydrophilic drugs with vsurf_W3 values below 417.56, can be excreted heavily 319	
through the bile if they are highly dipolar (AM1-dipole > 4.336) with high ratio of lipophilic 320	
to total surface area (FASA_H > 0.50), especially if they are predominantly in the ionized 321	
form at pH 7.4 (fU £ 0.052). On the other hand compounds with low dipole moment have 322	
low biliary excretion specially if they are lipophilic with logD(6.5) > 2.51 (node 9) or 323	
otherwise if they contain a high ratio of nitrogen atoms in the molecular structure (node 15). 324	
N ratio is low for larger alkaloids such as morphine or non-basic compounds such as estrone 325	
3-sulphate which will have moderate biliary excretion especially if they are hydrophilic 326	
(PEOE_VSA-0 ≤ 94.24). 327	
RT (2) was a result of molecular weight being employed in the first split using the Interactive 328	
C&RT analysis in STATISTICA (Figure 3). The statistically selected molecular weight 329	
threshold was 347.9 Da, with the compounds below this weight showing lower LogBE% 330	
values than the larger compounds. The tree shows that large (MW > 347.9) hydrophilic 331	
compounds (vsurf_CW4 > 0.540) have higher biliary excretion, particularly those with large 332	
total negative van der waals surface area (PEOE_VSA_NEG) and low surface area 333	
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corresponding to highly polarisable groups  (SMR_VSA7), especially if they are highly 334	
branched (SssssC>-1.812). Within this group of compounds, larger molecules with KierA1 > 335	
21.135 will have even higher biliary excretion. Other parameters of RT (2) indicate that high 336	
hydrophilic integy moment (vsurf_IW2) (node 13) and fractional negative charge weighted 337	
surface area (FCASA-) (node 11) would result in high LogBE% value.  338	
Recent studies by Yang et al (19) show that presence of carboxylic acid group(s) may 339	
indicate a trend towards increased biliary excretion. Therefore, the impact of presence of 340	
carboxylic acid group was examined using the interactive C&RT analysis with COOH used 341	
as the first partitioning molecular descriptor (Figure 4). According to RT (3), compounds 342	
containing at least one carboxylic acid group have higher biliary excretion levels. 343	
Furthermore, RT (3) indicated that compounds with lower total negative partial charge 344	
(PEOE_PC-) have much higher biliary excretion (node 6). These are large hydrophilic 345	
compounds with many negatively charged atoms. Non-acidic compounds in node 2 will have 346	
high biliary excretion if the negative charge weighted surface area for these molecules is high 347	
(node 5). CASA- has an element of size as well as indicating the presence of negatively 348	
charged groups such as sulphates. 349	
  350	
Table III. Statistical parameters of the models for training and test sets; RT is regression tree; 351	
BT is boosted trees and RF is random forest model 352	
Model Group Risk Estimate Standard Error 
RT (1)	 Train 0.112 0.040 
Validation 0.583 0.116 
RT (2)	 Train 0.229 0.034 
Validation 0.348 0.081 
RT (3)	 Train 0.323 0.050 
Validation 0.349 0.075 
BT (1) Train 0.079 0.007 
Validation 0.328 0.103 
BT (2) Train 0.078 0.007 
Validation 0.329 0.107 
RF Train 0.262 0.047 
Validation 0.311 0.076 
 353	
 354	
Boosted Trees 355	
	16	
	
Boosted tree module computes a sequence of simple trees, where each successive tree is built 356	
for the prediction of the residuals of the preceding trees. The analysis using various 357	
combination of model parameters resulted in two best models selected based on the error 358	
level for the internal test set (Table III). In models BT (1) and BT (2), the optimal numbers of 359	
trees were 145 and 147, with the learning rate of 0.10 and subsample proportions of 0.55 and 360	
0.60, respectively.  361	
It is possible to elucidate the influential descriptors in boosted trees analysis using variable 362	
importance calculation. Variable importance in STATISTICA is calculated as the relative 363	
(scaled) average value of the predictor statistic over all trees and nodes; hence these values 364	
reflect on the strength of the relationship between the predictors and the dependent variable 365	
of interest, over the successive boosting steps (STATISTICA help file, 2009). Included in 366	
Table I are the top 10 most important molecular descriptors of BT (1) and BT (2) models. 367	
Some of the descriptors used by BT models are those already observed in RT and MLR 368	
model. For example, LogD (6.5) is present in two RT models and it is amongst the top 10 369	
most significant descriptors of both BT models. Other descriptors selected by these models 370	
are, topological/ size descriptors (KierA3, Kier2, Kier3) and other lipophilicity descriptors 371	
such as Log D at different pH values and vsurf descriptors. Table III shows the statistical 372	
significance of these models. Graphs of average squared error against number of trees for 373	
training and cross-validated test sets (Figures S6 and S7 for BT (1) and BT (2)) and plots of 374	
observed vs calculated logBE% using BT (1) and BT (2) (Figures S8-S9) can be found in 375	
Supplementary Material II.  376	
 377	
Random forest  378	
In random forest (RF), the number of trees specifies the number of simple regression trees to 379	
be computed in successive forest building steps. The model development used the default 380	
values of the software with the number of trees set at 100. The graph of average squared error 381	
against number of trees for training and cross-validated test sets indicates that the test and 382	
training set errors reach a plateau at around 10 – 15 trees (See Supplementary Material II, 383	
Figure S10). The best model was achieved with a subsample proportion of 0.60, random test 384	
data proportion of 0.2 and number of trees of 100. Table I includes a description of the 10 385	
most significant descriptors employed in this model. Table III gives a summary of the 386	
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statistical parameters of the RF model. Observed vs calculated logBE% using the RF model 387	
can be found in Supplementary Material II (Figures S11). 388	
 389	
Validation of the models   390	
All models were validated by the same external validation set which had been set aside and 391	
not used at any stage of model development. Table IV shows the prediction accuracy of the 392	
QSAR models using external validation in terms of the mean absolute error and the number 393	
of outliers. In addition an average estimate of log BE% using all regression trees (RT (1)-RT 394	
(3)) was calculated and compared with the observed values to investigate any possible 395	
improvements in prediction accuracy. Table IV gives the performance of this estimation 396	
method (consensus RTs). 397	
 398	
Table IV. Summary of the prediction accuracy of the QSAR models and the number of 399	
outliers with absolute error above 0.6 400	
 401	
     402	
DISCUSSION  403	
Biliary excretion can play a significant role in the elimination of drugs and therefore its 404	
prediction is an important target in drug discovery. In the Pharmaceutical Industry, drug 405	
candidates are routinely tested in animal studies to measure the extent of biliary excretion and 406	
propensity of enterohepatic cycling, which have significant roles in the pharmacokinetics of a 407	
drug. In drug discovery, a reliable, user friendly and low cost model based on computer 408	
generated molecular properties can reduce the number of high cost animal (mainly rat) 409	
studies. This investigation aimed to elucidate how biliary excretion of compounds is 410	
Model MAE for training set MAE for validation set Outliers 
MLR 0.377 0.483 11 
RT (1)	 0.304 0.373 6 
RT (2)	 0.345 0.451 10 
RT (3)	 0.424 0.468 12 
Consensus RTs 0.319 0.383 7 
BT (1) 0.229 0.412 8 
BT (2) 0.226 0.417 7 
RF 0.403 0.496 14 
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controlled by their molecular structure, and to develop predictive models based on the 411	
molecular structure. Linear regression analysis, regression trees and two ensemble methods, 412	
boosted trees and random forest, were used for the QSAR model development.  413	
 414	
Comparison of the models 415	
Linear regression equation is one of the simplest and the most common QSAR techniques. 416	
This method has the benefit of easy interpretation and it can provide mechanistic insight into 417	
the process under investigation. However, it has been argued that many biological processes 418	
have more complex relationships with the molecular attributes of the compounds and hence 419	
linear regression models may fail to capture these (29). Regression trees (RT) offer a suitable 420	
alternative to MLR method with the advantage of being flexibly non-linear while retaining 421	
the interpretability (30). Ensemble methods such as random forest (22) provide consensus 422	
predictions which may have improved accuracy. But this is often accompanied by a loss of 423	
interpretability, as the ensemble of many models is often used as a ‘black box’ prediction tool. 424	
In this investigation, STATISTICA variable importance analysis was used to find the most 425	
significant molecular descriptors in the boosted trees and random forest models.  426	
According to Table IV, the most predictive model with the lowest estimation error for the 427	
external validation set is RT (1) followed by BT (1) and BT (2) and then RT (2). In other 428	
words, increasing the complexity of the models by allowing non-linear relationships and an 429	
ensemble of such models has been able to improve the prediction accuracy in comparison 430	
with a simple linear regression model (MLR). Table IV shows the number of outliers from 431	
each of the models. According to this table, RT (1) followed by BT (2) and BT (1) and then 432	
RT (2) are the best externally validated models with the lowest numbers of outliers in the 433	
validation set. The advantage of RT is the obvious simplicity and interpretability which can 434	
make it more popular with the end users in drug discovery disciplines. For example, when 435	
using the tree for a new compound, the molecular descriptors used in the tree will need to be 436	
calculated for the compound and then the terminal node (leaf) where the compound falls 437	
according to the molecular descriptor values should be identified. The average LogBE% of 438	
the terminal node (Mu) is the estimate of the tree for this compound. Despite that RT 439	
provides discrete predictions of a continuous observation which is not ideal, this is a much 440	
more straightforward procedure than using BT or RF for the estimation of BE%. These 441	
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models are ensemble of many trees and therefore the prediction has to be performed by the 442	
computer rather than manually. 443	
An interesting observation was made as MW and COOH were not significant in MLR 444	
equation when forced into stepwise regression analysis (P > 0.05). Despite this, incorporation 445	
of these two parameters was statistically significant in CART analysis resulting in RT (2) and 446	
RT (3). This indicates the non-linear nature of the impact of these two parameters on biliary 447	
excretion. Average prediction by the three RT models was also considered and found to be of 448	
similar accuracy to RT (1) (Table IV). 449	
In this work, the MLR model based on the training set of 168 compounds had the second 450	
poorest prediction accuracy after RF. Studies by Yang et al (19) and Chen et al (23) report 451	
MLR models based on training sets of 37 and 46 compounds, respectively. The proposed 452	
model by Yang et al incorporated molecular connectivity indexes and atom-type 453	
electrotopological indexes which have also been used in this study. The model proposed by 454	
Chen et al also incorporated similar molecular descriptors to our study, with the addition of 455	
Abraham descriptors representing polarisability and hydrogen bond acceptor capacity. 456	
Although we have not used Abraham’s descriptors, there are other molecular descriptors in 457	
our set of 386 descriptors that measure the same properties. Examples are the number of 458	
hydrogen bonding acceptor atoms and atomic charge on the most negatively charged atom in 459	
the molecule which may represent hydrogen bond acceptor ability (31) and molar refractivity 460	
descriptors which may indicate molecular polarisability (32).  461	
In another study, Luo et al (17) used 50 proprietary compounds from Bristol-Myers Squibb 462	
Co. for model development. They also developed a multiple linear regression model, but in 463	
addition to more common molecular descriptors, they employed free energy of aqueous 464	
solvation calculated from a self-consistent reaction field method. In analysing this model, 465	
Gandhi and Morris (18) found that the model failed to generalise further to the new set of 466	
compounds and specifically free energy of aqueous solvation was not statistically significant. 467	
They argued that a complex process such as hepatobiliary excretion cannot be captured by 468	
simple physicochemical properties when examining chemically dissimilar compounds. 469	
Indeed such extrapolations to external compounds will fail when the compounds are outside 470	
the domain of applicability of the QSAR models. Incorporation of a larger dataset in this 471	
work may provide the opportunity for capturing an extended chemical space. This will be 472	
discussed further when analysing the outliers in the next two sections. 473	
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 474	
Structural features of compounds for biliary excretion 475	
Table I gives a brief description of the significant molecular descriptors used in the models. 476	
For the sake of this discussion, the descriptors in this work can be classified roughly into five 477	
categories: lipophilicity, ionization, molecular size, and topological and constitutional 478	
descriptors.  479	
It can be seen in Table I that lipophilicity descriptors such as log D at different pH levels and 480	
surface area of hydrophilic molecules (SlogP_VSA0) are present in all models. In all 481	
interpretable models (except linear regression equations) lipophilicity descriptors show a 482	
negative effect on the biliary excretion of compounds. This may relate to the fact that highly 483	
lipophilic compounds are known to be highly extracted and metabolised in the liver (33) 484	
rather than being excreted unchanged through bile or kidney. For example metabolism by 485	
cytochrome P450 enzymes (34) and (UDP)-glucuronosyltransferase (35) is mainly controlled 486	
by lipophilicity and increased for more lipophilic compounds. There have been inconsistent 487	
findings in the literature regarding the effect of lipophilicity on the biliary excretion of 488	
xenobiotics. Proost et al found no significant correlation between lipophilicity and biliary 489	
excretion of series of bulky organic cations despite it being the predominant factor for the 490	
degree of plasma protein binding and hepatic uptake rate (33). Similar observations have 491	
been made for other compilations of biliary excretion data (19). Other studies indicate 492	
negative effect of lipophilicity on the biliary excretion within the range of compounds studied 493	
(17, 36). Lipophilicity has been associated with many models of ADME properties (37). It is 494	
a well established fact that compounds with higher logP have poor aqueous solubility and are 495	
more likely to pass through lipid bilayer of biological membranes (38). The general trend in 496	
the literature with regards to the role of lipophilicity in pharmacokinetic processes indicates 497	
that more lipophilic compounds have higher oral absorption, plasma protein binding, and 498	
volume of distribution (39-41) and are more prone to P450 metabolism (34, 39). This may 499	
lead to the reduced chance of excretion through bile as the intact drug. 500	
All models presented in this work indicate the significant role of ionisation and polarity 501	
through molecular descriptors such as COOH, fU, FCASA- and SddssS_acnt. Acids are able 502	
to ionise into anions which are substrates of several transporters (generally organic anion 503	
transporters). Compounds that carry positive as well as negative charge or partial charges can 504	
use both the “organic anion” and the “organic cation” transport systems (42). For example 505	
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OAT3 accepts various kinds of bulky hydrophobic anions, while OAT1 can transport 506	
relatively hydrophilic small molecules, such as nucleoside analogues (43). Besides, 507	
monocarboxylate transporters (MCT1 to MCT14) constitute a family of proton-linked plasma 508	
membrane transporters that carry molecules having one carboxylate group. MCT1 is 509	
expressed nearly all over in every tissue in the human body and also in rat and calves 510	
hepatocytes (44). MCT2 is abundant on the surface of human, rat and hamster hepatocytes 511	
(45). MCT5 and MCT8 are also known to play transporting role in rat hepatocytes (45). 512	
Studies of biliary excretion of exogenous compounds have indicated the relation between 513	
polarity and biliary excretion stating that possession of a strongly polar anionic group was 514	
important factor in appreciable biliary excretion (17, 46). In all the interpretable models 515	
reported here, polarity descriptors show a positive impact on biliary excretion. Examples are 516	
the positive coefficients of dipole moment (AM1_dipole) in the linear regression equation 517	
and higher % of compounds with lower unionised fractions at pH 7.4 (fU) in RT (1). 518	
Molecular size is the other important factor in biliary excretion represented in the models by 519	
molecular descriptors such as kappa shape indexes, hydrophobic volumes (vsurf_W1 and 520	
vsurf_W3), and surface areas of atoms with specific charge or lipophilicity ranges (e.g. 521	
PEOE_VSA_NEG and PEOE_VSA_HYD). These molecular descriptors show positive effect 522	
on biliary excretion level in all models. This is in line with the common understanding that a 523	
molecular weight threshold may apply to biliary excretion of compounds, and that high 524	
molecular weight compounds may be predominantly excreted through bile (19, 36 and 46). 525	
Yang et al. (19) suggested a molecular weight threshold value of 400 Da for biliary excretion 526	
of anionic drugs in rats using 164 drugs. In this study, regression tree analysis found the 527	
threshold value for molecular weight to be at 347.9 Da for biliary excretion in rat (RT (2)). 528	
Incidentally, this regression tree had the highest prediction accuracy for the external 529	
validation set amongst all the RT models. This was despite the fact that molecular weight was 530	
not the descriptor of choice by C&RT analysis. 531	
The incorporation of some structural fragments in the models gave interesting information 532	
regarding molecular requirements for biliary excretion. Examples include SddssS_acnt and 533	
SsssCH which indicate higher biliary excretion of compounds containing sulphate groups and 534	
branched structure (MLR). Compounds containing carboxylic acid groups are also more 535	
likely candidates for biliary excretion according to RT (3). Up to half of compounds in our 536	
dataset contain –COOH groups (103 compounds out of 217). 65 out of 103 COOH containing 537	
compounds had biliary excretion of > 20%. Varma et al (36) have analysed the 538	
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interconnection between physicochemical requirements of OATP substrates and the biliary 539	
excretion rates. It was then suggested that substrate specificity of OATPs including acidity 540	
may primarily indicate the elimination through bile (36).  541	
 542	
Analysis of the outliers 543	
There are a number compounds that are outliers from majority of the models. Analysis of 544	
outliers may provide interesting information regarding the applicability of the models. Within 545	
the BE% range, it could be observed that compounds with low biliary excretion show a 546	
higher average error in general (Table V). For example, the average error by all seven models 547	
was the highest for the 6 compounds with the extremely low biliary excretion (BE% < 0.23), 548	
followed by the compounds with 0.23< BE% < 1.23 (-0.64< logBE% < 0.09). A closer 549	
inspection of the data reveals that despite the high average error for the 6 compounds with 550	
low biliary excretion, the estimation may still be acceptable as all these compounds have 551	
been estimated to have a BE% value < 4% (average of all models) and below 0.6% by RT1 552	
model with only one exception (benzoic acid). A hypothesis here could be that these 553	
compounds may have suitable properties for higher biliary excretion, but other routes of 554	
elimination are predominating. For example, it has been shown for benzoic acid that when 555	
clearance by the kidney is prevented, biliary excretion increases by 10% (12). Out of 217 556	
compounds in the dataset, the predominant routes of elimination are biliary excretion for 115 557	
compounds, renal excretion for 65 compounds and metabolism for 37 compounds. However, 558	
the outlier compounds do not belong to any single groups above in terms of the predominant 559	
routes of elimination.  560	
According to Table V, highly lipophilic compounds (log P > 5.35) and low molecular weight 561	
compounds (MW £ 280) also show higher error rates and this may need to be considered 562	
when using the models for the prediction of external compounds.  563	
 564	
Table V. Average MAE by nine models for compounds with various BE%, logP and 565	
molecular weight values 566	
BE%	 Average	MAE	 n	
<=	0.23	 1.12	 6	
0.23	-	1.23	 0.50	 26	
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>	1.23	 0.30	 176	
MW	(Da)	
	 	>	280	 0.31	 173	
<=	280	 0.54	 35	
Log	P	
	 	>5.35	 0.63	 13	
<=5.35	 0.33	 195	
 567	
Table VI gives a list of the compounds that are outliers in six or seven models out of the 568	
seven models proposed here. In addition there are four compounds which were outliers in 569	
four or five models but had exceptionally high average error from the seven models. These 570	
compounds were part of the training or validation sets but none were omitted from average 571	
error calculations.  572	
Table VI. Outlier compounds in training or validation sets with absolute error of > 0.6 in 573	
more than five out of seven models and their BE% values 574	
Outliers BE% LogBE% Over or under prediction Models with error MW 
Benzoic acid 0.09 -1.07 over-predicted except for BT 
models 
4 122 
EMDP 0.20 -0.69 over-predicted 6 263 
Fosmidomycin 0.10 -1.00 over-predicted 7 183 
Nelfinavir 0.05 -1.32 over-predicted 5 567 
EDDP  36.31 1.56 under-predicted 6 277 
PAEB 31.62 1.50 under-predicted 7 222 
Tolrestat 53.70 1.73 under-predicted 6 357 
 575	
The outliers in Table VI have been over- or under-predicted by the models. One compound in 576	
the table has shown underestimation by some and overestimation by other models; biliary 577	
excretion of benzoic acid was overestimated by all models except for BT (1) and BT (2). It 578	
can be seen in Table VI that fosmidomycin, nelfinavir and EMDP are over-predicted by five 579	
or more models. Benzoic acid is rapidly cleared by the kidney so it may not have enough time 580	
to pass into the bile (12). Abou-El-Makarem and his colleagues examined this possibility by 581	
tying up the renal pedicles in rats, so that clearance by the kidney was prevented and the 582	
results indicated that when clearance by the kidney is prevented, biliary excretion increased 583	
by 10% (12). Fosmidomycin has a short half-life of 1.7 hours and is rapidly cleared by the 584	
kidneys (47). It is a small molecular weight polar agent which may not be cleared in high 585	
quantities through bile according to the molecular weight threshold hypothesis. Despite the 586	
use of molecular size descriptors this compound still appeared to be overestimated by all 587	
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seven models, even using RT (2) which has employed MW for the first branching. The 588	
problem with RT (2) in relation to this compound is that although this compound falls into 589	
node 2 along with 44 other low molecular weight compounds, this node has an average 590	
LogBE% of 0.42 which is much lower than node 3 with an average LogBE% of 1.27 but not 591	
low enough for this compound. Likewise, other models have indicated low biliary excretion 592	
of small sized compounds, but somehow, estimation is higher than what is actually observed.  593	
Nelfinavir has a half-life of 3.5 to 5 hours and is eliminated via metabolism by the 594	
cytochrome P450 enzyme system (48). This is a highly lipophilic compound which is poorly 595	
excreted through bile, and is predicted as such by the models (predicted BE% below 2% 596	
using all models except for RT (3) and RF which predict 13% and 7.6% respectively). 597	
EMDP (2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline) is a major metabolite of methadone 598	
which has been over-predicted by most models despite a very low biliary excretion. As with 599	
nelfinavir, the predicted BE% for this compound by most models is quite low at <4% (MLR 600	
is an exception) and the selected model, RT (1), predicts a biliary excretion value of ~0.3%. 601	
Despite this, in comparison with the extremely low observed value of 0.05%, the predicted 602	
values are much higher, leading to a numerically large average error, even though 603	
qualitatively, the predicted biliary excretion may be reasonably low. 604	
EDDP, PAEB (procaine amide ethobromide) and tolrestat are the under-predicted compounds. 605	
All these compounds have high BE% values at 36%, 32% and 54%. This is despite the 606	
relatively low molecular weights of EDDP and PAEB which are below the defined MW 607	
threshold of 347 Da for biliary excretion. The exact mechanism of high biliary excretion of 608	
these compounds warrants further investigation to explore the reasons behind such high 609	
biliary excretion despite the low molecular weight.  610	
Tolrestat has a relatively high molecular weight suitable for biliary excretion and a COOH 611	
group making it a suitable substrate for OATPs (36).  Despite this, the hydrophilic volume 612	
calculated by the VolSurf descriptor vsurf-W3 is not high enough to put this compound in 613	
node 3 rather than node 2 of RT (1) model. In RT (2) the compound falls into node 16, which 614	
is due to the lack of non-aromatic branched structure which would place it in node 17 with a 615	
higher predicted BE%.  Likewise, in RT (3) this compound fails to be placed in node 7 and 616	
falls in node 6 instead, due to the low total negative charge (> -2.33)  as a result of the low 617	
number of negatively charged atoms. This indicates a shortcoming in the above mentioned 618	
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models which lack suitable parameters that can capture the relative polarity in relation to the 619	
molecular size.  620	
 621	
CONCLUSION 622	
This investigation focused on the development of computational models for a cost-effective 623	
estimation of biliary excretion of compounds. This was made possible through the application 624	
of Quantitative Structure-Activity Relationships where molecular properties (descriptors) of a 625	
large dataset of compounds were related to the percentage of dose excreted intact via the bile 626	
through the use of statistical techniques. Some of the statistical techniques led to very 627	
promising results as evaluated by the prediction accuracy for the external validation set. The 628	
QSAR models also identified the important molecular properties (descriptors) that have the 629	
main influence on biliary excretion of compounds. The selected models were the regression 630	
tree (CART) model, RT (1), followed by boosted trees models BT (1) and BT (2). Regression 631	
trees also have the advantage of being simple, interpretable and user-friendly. The models 632	
generally indicated that larger, relatively hydrophilic molecules containing a carboxylic acid 633	
group are more prone to biliary excretion. For example in the selected model, RT (1), 634	
compounds with increased hydrophilic volume and acidic dissociation have high biliary 635	
excretion. The significance of acidity and molecular size were further confirmed through 636	
interactive regression trees and a statistically validated MW threshold for effective biliary 637	
excretion was established. Detailed analysis of the error levels and outliers indicated that the 638	
models work best for larger compounds (MW > 280 Da) and are less accurate for extremely 639	
lipophilic compounds (log P > 5.35). 640	
 641	
REFERENCES 642	
1. Rosenbaum SE. Basic pharmacokinetics and pharmacodynamics, an integrated textbook 643	
and computer simulations. 1st ed. Hoboken, New Jersey: John Wiley and Sons; 2011. 644	
2. Rollins DE, Klaassen CD. Biliary excretion of drugs in man. J Clin Pharmacokinet. 645	
1979;4:368-379. 646	
3. Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic Transport of Bile Salts. 647	
Semin Liver Dis. 2000;20:273-92. 648	
4. Van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK. 649	
Drug uptake systems in liver and kidney. Curr Drug Metab.	2003;4:185-211. 650	
	26	
	
5. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, De la cruz M, Johns SJ, 651	
Stryke D, Kawamoto M, Urban TJ. Natural variation in human membrance transporter 652	
genes reveals evolutionary and functional constraints.	 Proc Natl Acad Sci USA. 653	
2003;100:5896-5901. 654	
6. Nies AT, Koepsell H, Winter S, Burk O, Klein K, Kerb R, Zanger UM, Keppler D, 655	
Schwab M, Schaeffeler E. Expression of organic cation transporters OCT1 (SLC22A1) 656	
and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. 657	
Hepatol. 2009;50:1227-40. 658	
7. Trauner M, Boyer JL. Bile Salt Transporters: Molecular characterization, function, and 659	
regulation. Physiol Rev. 2003;83:633–71.  660	
8. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, 661	
Afshari CA, R, Hamadeh HK. Interference with bile salt export pump function is a 662	
susceptibility factor for human liver injury in drug development. Toxicol Sci. 663	
2010;118:485-500. 664	
9. Schinkel AH, Mayer U, Wagenaar E, Mol C.A, Deemter LV, Smit JJ, Valk MA, 665	
Voordouw AC, Spits H, Tellingen OV, Zijlmans JM, FiBbe WE, Borst P. Normal 666	
viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-667	
glycoproteins. Proc Natl Acad Sci USA. 1997;94: 4028–33. 668	
10. Merino G, Jonker JW, Wagenaar E, van Herwaarden AE, Schinkel AH. The breast 669	
cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary 670	
excretion, and milk secretion of the antibiotic nitrofurantoin. Mol Pharmacol. 2005; 671	
67:1758-64. 672	
11. Hirom PC, Millburn P, Smith RL, Williams RT. Species variations in the threshold 673	
molecular-weight factor for the biliary excretion of organic anions. Biochem J. 674	
1972;129,1071–7. 675	
12. Abou-El-Makarem MM, Millburn P, Smith RL, Williams RT. Biliary excretion in 676	
foreign compounds. Species difference in biliary excretion. Biochem J. 1967;105:1269–677	
74. 678	
13. Crosignani A. Clinical pharmacokinetics of therapeutic bile acids. J Clin Pharmacokinet. 679	
1996;30:333-58.  680	
14. Neef C, Keulemans KT, Meijer DK. Hepatic uptake and biliary excretion of organic 681	
cations--I. Characterization of three new model compounds. Biochem Pharmacol. 682	
1984;33:3977-90. 683	
15. Feitsma KG. Unequal disposition of enantiomers of the organic cation oxyphenonium in 684	
the rat isolated perfused liver. J Pharm Pharmacol. 1989;41:27-31.  685	
16. Ghafourian T, Barzegar-Jalali M, Dastmalchi S, Khavari-Khorasani T, Hakimiha N, 686	
Nokhodchi A. QSPR models for the prediction of apparent volume of distribution. Int J 687	
Pharm. 2006;319:82–97. 688	
17. Luo G, Johnson S, Hsueh M, Zheng J, Hong C, Xin B, Chong S, He K, Harper TW. In 689	
silico prediction of biliary excretion of drugs in rats based on physicochemical 690	
properties. Drug Metab Dispos. 2010;38:422-30. 691	
18. Gandhi YA, Morris ME. Re-evaluation of a quantitative structure pharmacokinetic 692	
model for biliary excretion in rats. Drug Metab Dispos. 2012;40:1259-62. 693	
	27	
	
19. Yang X, Gandhi YA, Duignan DB, Morris ME. Prediction of biliary excretion in rats 694	
and humans using molecular weight and quantitative structure–pharmacokinetic 695	
relationships. AAPS. 2009;11:511–25.  696	
20. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. 697	
Monterey, CA: Wadsworth & Brooks/Cole Advanced Books & Software. 1984. 698	
21. Lewicki P, Hill S. Statistics, methods and applications, a comprehensive reference for 699	
science, industry and data mining. 1st ed. USA: StatSoft Inc; 2006.  700	
22. Breiman L. Random forests. Machine learning. 2001;45:5-32. 701	
23. Chen Y, Cameron K, Guzman-Perez A, Perry D, Li D, Gao H. Structure-702	
pharmacokinetic relationship of in vivo rat biliary excretion. Biopharm Drug Dispos. 703	
2010;31:82-90. 704	
24. Zamek-Gliszczynski MJ, Hoffmaster KA, Humphreys JE, Tian X, Nezasa K, Brouwer 705	
KLR. Differential Involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in Biliary Excretion 706	
of 4-Methylumbelliferyl Glucuronide and Sulfate in the Rat. J Pharmacol Exp Ther. 707	
2006;319:459-67. 708	
25. Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber 709	
BW. Metabolism And Disposition of the HIV-1 Protease Inhibitor Ritonavir (ABT-538) 710	
in Rats, Dogs, and Humans. Drug Metab Dispos. 1997;25(4):489-501. 711	
26. Fischer V, Rodríguez-Gascón A, Heitz F, Tynes R, Hauck C, Cohen D, Vickers AE. 712	
The multidrug resistance modulator valspodar (PSC 833) is metabolized by human 713	
cytochrome P450 3A. Implications for drug-drug interactions and pharmacological 714	
activity of the main metabolite. Drug Metab Dispos. 1998;26(8):802-11. 715	
27.  Shi J, Montay G, Bhargava VO. Clinical pharmacokinetics of telithromycin, the first 716	
ketolide antibacterial. Clin Pharmacokinet. 2005;44(9):915-34. 717	
28. QuaSAR: The MOE System for QSAR. Chemical Computing Group Inc; 2013. 718	
Available from: URL: http://www.chemcomp.com/journal/qsar.htm. 719	
29. Guha R, Jurs PC. Development of linear, ensemble, and nonlinear models for the 720	
prediction and interpretation of the biological activity of a set of PDGFR inhibitors. J 721	
Chem Inf Comput Sci. 2004;44:2179-89. 722	
30. De'ath G, Fabricius KE. Classification and Regression Trees: A powerful yet simple 723	
technique for ecological data analysis. Ecology. 2000;81:3178-92. 724	
31. Dearden JC, Ghafourian T. Hydrogen bonding parameters for QSAR: comparison of 725	
indicator variables, hydrogen bond counts, molecular orbital and other parameters, J 726	
Chem Inf Computer sci. 1999;39: 231-235. 727	
32. Verma RP, Hansch C. A comparison between two polarizability parameters in 728	
chemical–biological interactions, Bioorg Med Chem. 2005;13: 2355-2372. 729	
33. Proost JH, Roggeveld J, Wierda JM, Meijer DK. Relationship between chemical 730	
structure and physicochemical properties of series of bulky organic cations and their 731	
hepatic uptake and biliary excretion rates. J Pharmacol Exp Ther. 1997;282:715-26. 732	
34. Lewis DF, Ito Y. Human CYPs involved in drug metabolism: structures, substrates and 733	
binding affinities. Expert Opin Drug Metab Toxicol. 2010;6:661-74. 734	
35. Smith PA, Sorich MJ, McKinnon RA, Miners JO. In silico insights: chemical and 735	
structural characteristics associated with uridine diphosphate glucuronosyltransferase 736	
substrate selectivity. Clin Exp Pharmacol Physiol. 2003;30:836-40. 737	
	28	
	
36. Varma MV, Chang G, Lai Y, Feng B, El-Kattan AF, Litchfield J, Goosen TC. 738	
Physicochemical property space of hepatobiliary transport and computational models 739	
for predicting rat biliary excretion. Drug Metab Dispos. 2012;40:1527-37. 740	
37. Hansch C, Leo A, Mekapati SB, Kurup A. QSAR and ADME. Bioorg Med Chem. 741	
2004;12:3391-3400. 742	
38. Kerns EH, Di L. Drug-like properties: Concepts, structure, design and methods. 1st ed. 743	
London: Elsevier; 2008. 744	
39. van de Waterbeemd H, Smith DA, Jones BC. Lipophilicity in PK design: methyl, ethyl, 745	
futile. J Comput Aided Mol Des. 2001;15:273-86. 746	
40. Obach RS, Lombardo F, Waters NJ. Trend analysis of a database of intravenous 747	
pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 748	
2008;36:1385-405. 749	
41. Newby D, Freitas AA, Ghafourian T. Coping with unbalanced class datasets in oral 750	
absorption models, Journal of Chemical Information and Modeling. J Chem Inf Model. 751	
2013;53: 461-74. 752	
42. Koepsell H, Gorboulev, Popp C, van Montfoort JE, Meier PJ, Arndt P, Volk C. Organic 753	
cation transporters in the sinusoidal membrance of hepatocytes. In: Matern S, Boyer JL, 754	
Keppler D, Meier-Abt PJ, editors. Hepatobiliary transport from bench to beside. London: 755	
Kluwer Academic; 2001. p. 3-15. 756	
43. Maeda K, Shitara Y, Horie T, Sugiyama Y. Web-based database as a tool to examine 757	
drug-drug interactions involving transporters. In: Pang SK, Rodrigues DA, Raimund 758	
MP, editors. Enzyme and transporter-based drug-drug interactions. Progress and future 759	
challenges. London: Springer; 2010. p. 387-414. 760	
44. Kirat D, Inoue H, Iwano H, Yokota H, Taniyama H, Kato S. Monocarboxylate 761	
transporter 1 (MCT1) in the liver of pre-ruminant and adult bovines. Vet Journal. 762	
2007;173:124-30. 763	
45. Halestrap AP, Meredith D. The SLC16 gene family-from monocarboxylate transporters 764	
(MCTs) to aromatic amino acid transporters and beyond.	 Pflugers Arch. 2004;447:619-765	
28.  766	
46. Millburn R, Smith RL, Williams RT. Biliary excretion of foreign compounds. Biochem 767	
J. 1967;105:1275-81. 768	
47. Murakawa T, Sakamoto H, Fukada S, Konishi T, Nishida M. Pharmacokinetics of 769	
fosmidomycin, a new phosphonic acid antibiotic. Antimicrob Agents Chemother. 770	
1982;21:224-30.  771	
48. Bardsleey-Elliot A, Plosker GL. Nelfinavir an update on its use in HIV infection. Drugs. 772	
2000;59:581-620.  773	
	29	
	
Legend to figures 774	
775	
Figure 1. The cartoon depicts substrate transport processes in the hepatocyte including 776	
sinusoidal and canalicular proteins efflux (E) and uptake (U) transport of drugs/drug-likes 777	
and their metabolites. 1. Sinusoidal membrane., 2. Ito cell., 3. Space of disse., 4. Hepatocyte., 778	
5. Mitochondria., 6. Nucleus., 7. Endoplasmic reticulum., 8. Lysosomes., 9. Peroxisome. 779	
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780	
Figure 2. RT (1) developed using the training set with the descriptors selected by C&RT. 781	
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782	
Figure 3. RT (2) developed using interactive C&RT analysis using molecular weight as the 783	
first descriptor. 784	
	32	
	
785	
Figure 4. RT (3) using the number of carboxyl groups (COOH) as the first descriptor. 786	
 787	
